Report overview
Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectious retinitis, macular edema, macular hole, retinoblastoma, retinal degeneration, retinoschisis and uveitis etc. There are various types of retinal disorders but most of them cause visual symptoms.
This report aims to provide a comprehensive presentation of the global market for Retinal Disorders Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Disorders Therapy. This report contains market size and forecasts of Retinal Disorders Therapy in global, including the following market information:
Global Retinal Disorders Therapy Market Revenue, 2018-2023, 20242035, ($ millions)
Global top five companies in 2022 (%)
The global Retinal Disorders Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Age Related Macular Degeneration Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Retinal Disorders Therapy include ALLERGAN, AbbVie, Alimera Sciences, Janssen Biotech, Swedish Orphan Biovitrum, Roche, Bristol-Myers Squibb, Genzyme and Genentech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Retinal Disorders Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retinal Disorders Therapy Market, by Type, 2018-2023, 20242035 ($ millions)
Global Retinal Disorders Therapy Market Segment Percentages, by Type, 2022 (%)
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Global Retinal Disorders Therapy Market, by Application, 2018-2023, 20242035 ($ millions)
Global Retinal Disorders Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Retinal Disorders Therapy Market, By Region and Country, 2018-2023, 20242035 ($ Millions)
Global Retinal Disorders Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Retinal Disorders Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Retinal Disorders Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Aier Eye Hospital
Alcon Holdings, Inc.
Eyebright Medical
Kanghong Pharmaceutical
Huaxia Eye Hospital
Xingqi Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Retinal Disorders Therapy, market overview.
Chapter 2: Global Retinal Disorders Therapy market size in revenue.
Chapter 3: Detailed analysis of Retinal Disorders Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Retinal Disorders Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
